Biotech entity

Planned Parenthood Action Fund

organization

Every one of those 1 sits in a single category, pharma. Angela Vasquez-Giroux is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Planned Parenthood Action Fund, all published on July 12, 2026.

Last mentioned: Jul 12, 2026

Entity pulse

Recent coverage · Planned Parenthood Action Fund

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Planned Parenthood Action Fund

Every one of those 1 sits in a single category, pharma. Angela Vasquez-Giroux is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 3 original sources on average. We currently track 1 Biotech story that mention Planned Parenthood Action Fund, all published on July 12, 2026.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Planned Parenthood Action Fund. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Medicaid billing restored

    Planned Parenthood and two regional providers resume billing Medicaid for non-abortion services after nearly a year.

  2. Medicaid defunding enacted

    Trump administration tax and policy law mandates that abortion providers be excluded from all Medicaid reimbursement.

  3. Roe v. Wade overturned

    Supreme Court's Dobbs decision ends federal abortion rights, enabling state bans and increasing financial pressure on providers.

Stories mentioning Planned Parenthood Action Fund 1

Pharma Neutral

Birth Control Pill Prescriptions Fell 25% During Planned Parenthood Defunding, Hitting Pharma Markets

The year-long exclusion of Planned Parenthood from Medicaid led to a 25% decline in contraceptive prescriptions dispensed, affecting pharmaceutical sales volumes and signaling risk for manufacturers reliant on safety-net distribution channels. The funding restoration only partially alleviates the immediate demand shortfall, as clinic closures permanently remove points of dispensing.

3 sources

Source: kbzk.com · wxyz.com

Planned Parenthood Action Fund is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.